Skip to content
Tuesday, 3 November 2026Malta edition Ask cde.news Malta-24 Briefing @CDNewsDispatch EnglishMalti
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch
Ask cde.news
LATEST
US midterms open after tense final campaign push EU could allow UK to stay outside euro and Schengen if it seeks to rejoin Government must take responsibility for economic strategy, infrastructure planning and meeting its electoral commitments – Malta Employers FELTOM Calls for Fair Competition and Sustainable Growth at ICEF Berlin 2026 Iran says it can reopen Hormuz in two days if US meets conditions
WHO

WHO says AstraZeneca benefits outweigh risks; assessing latest data

cde.news desk · 1 min read
EnglishMaltiXinf
Tedros Adhanom Ghebreyesus, Director General of the World Health Organization (WHO), speaks during a visit of the Presidents of the Swiss Federal Chambers, at the World Health Organization (WHO) headquarters in Geneva, Switzerland, 15 October 2020. EPA-EFE/MARTIAL TREZZINI

The World Health Organization expects there will be no reason to change its assessment that the benefits of the AstraZeneca vaccine against COVID-19 outweigh any risks, a regulatory official told a news conference on Tuesday.

The WHO is closely studying the latest data alongside European and other regulators, in light of reports of blood clots among people who have been vaccinated, said Rogerio Gaspar, WHO director of regulation and prequalification.

He said the WHO expects to reach a fresh assessment on Wednesday or Thursday, but does not believe there will be a reason to change its advice that the benefits outweigh any risks. (Reporting by John Miller and Stephanie Nebehay Writing by Peter Graff; Editing by Kevin Liffey)

Filed under CoronavirusWHO
Topics AstraZenecaCoronavirus

Leave a Reply

More from WHO

More →
WHO

Cruise ship infections rise with the WHO now confirming eight cases

 WHO

WHO calls for urgent action on mental health

 WHO

WHO classifies JN.1 coronavirus strain as ‘variant of interest’